A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-c...

por LeCaer, H, Barlesi, F, Corre, R, Jullian, H, Bota, S, Falchero, L, Vergnenegre, A, Dujon, C, Delhoume, J Y, Chouaid, C
Publicado 2011

Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer

por Ricordel, Charles, Chaillot, L., Vlachavas, E. I., Logotheti, M., Jouannic, A., Desvallees, T., Lecuyer, G., Aubry, M., Kontogianni, G., Mastrokalou, C., Jouan, F., Jarry, U., Corre, R., Le Guen, Y., Guillaudeux, T., Lena, H., Chatziioannou, A., Pedeux, Rémy
Publicado 2023